International Journal of Drug Policy
Volume 18, Issue 2 , Pages 70-74, March 2007

Tobacco harm reduction: How rational public policy could transform a pandemic

Faculties of Law and Medicine, University of Ottawa, Canada

School of Health Sciences, Hunter College, City University of New York, United States

Montefiore Medical Center/Albert Einstein College of Medicine and Mailman School of Public Health, Columbia University, NY, United States

Received 4 October 2006

Abstract 

Nicotine, at the dosage levels smokers seek, is a relatively innocuous drug commonly delivered by a highly harmful device, cigarette smoke. An intensifying pandemic of disease caused or exacerbated by smoking demands more effective policy responses than the current one: demanding that nicotine users abstain. A pragmatic response to the smoking problem is blocked by moralistic campaigns masquerading as public health, by divisions within the community of opponents to present policy, and by the public-health professions antipathy to any tobacco-control endeavours other than smoking cessation. Yet, numerous alternative systems for nicotine delivery exist, many of them far safer than smoking. A pragmatic, public-health approach to tobacco control would recognize a continuum of risk and encourage nicotine users to move themselves down the risk spectrum by choosing safer alternatives to smoking – without demanding abstinence.

Keywords: Tobacco, Nicotine, Harm reduction, Cigarette smoking, Policy

 

PII: S0955-3959(06)00241-6

doi:10.1016/j.drugpo.2006.11.013

International Journal of Drug Policy
Volume 18, Issue 2 , Pages 70-74, March 2007